From Squamous Cell Carcinoma to Adenocarcinoma: Clinical Applications Driving the Anal Cancer Market
The clinical applications of anal cancer therapies span diverse histologies and disease stages, from squamous cell carcinoma to adenocarcinoma and rare subtypes. The Anal Cancer Market is benefiting from this diverse demand, valued at USD 1.04 billion in 2025 and projected to reach USD 2.06 billion by 2035 at a CAGR of 7.10%. This article explores the clinical applications driving...
0 Yorumlar 0 hisse senetleri 3 Views 0 önizleme